Kaitiaki Hauora warns that increasing privatisation of public healthcare, particularly ophthalmology services, risks undermining the training of future specialists and the sustainability of the
Dispensing opticians play a critical role in myopia management success by reinforcing optometrist recommendations, educating families on progression and treatment options, and ensuring patient adherence
The Australian and New Zealand Strabismus Society’s (ANZSS) annual meeting featured distinguished speakers Prof Andrea Molinari and Prof Fiona Rowe, covering str
Johnson and Johnson Vision’s (J&Js) breakthrough soft contact lens for myopia control, Acuvue Abiliti 1-Day, newly released data reveals over 55% of treated eyes showed no clinically meaningful myopia
The 76th RANZCO New Zealand Annual Scientific Conference in Queenstown covered key themes including cornea, ocular oncology, paediatric ophthalmology, cataract surgery
US neuro-optometrist Dr Bryce Appelbaum's brain-based vision training model improved UK GP Dr Rangan Chatterjee's una
This article explores 'phygital' technology, combining physical and digital elements, and its application in optometry, from virtual try-on eyewear to
An Eye Institute seminar covered interpreting OCT for intraocular tumours and macular disease, photobiomodulation for dry AMD, pterygium management, retinal haemorrh
An optometrist recounts her experience on an Eyes4Everest outreach trip to Nepal's Annapurna region, providing eyecare at high-altitude
Veteran Auckland optometrist Trevor Skinner retires after nearly 50 years, known for his patient-first approach, empathy, and passion for optometry, having
This month, Drew Jones covers Eye Institute’s Drs Peter Hadden’s and Sophie Hill’s responses to optometrists’ questions about vitrectomy recovery and counselling, anti-VEGF choices and emerging management options for geographic atrophy secondary to AMD. Answers have been abridged.
Artificial intelligence (AI) use in eyecare is moving fast, but are regulation, ethics and real-world integration keeping pace? As clinicians and regulators grapple with how to harness its potential without compromising patient safety or equity, Drew Jones examines where AI use in eyecare stands and